Advertisement
Screener

EXICURE, INC. (XCUR) Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

1.6 / 5 stars · 20/63 Roast Me

EXICURE, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

EXICURE, INC. (XCUR) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $627.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-25.

Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2022-03-25

  • 2021-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $627.00K.
  • 2021-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $699.00K.
  • 2021-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $770.00K.
  • 2021-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $841.00K.
Period endDebt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
2021-12-31$627.00K
10-K · filed 2022-03-25
2021-09-30$699.00K
10-Q · filed 2021-11-19
2021-06-30$770.00K
10-Q · filed 2021-08-12
2021-03-31$841.00K
10-Q · filed 2021-05-12
2020-12-31$911.00K
10-K · filed 2021-03-11
2020-09-30$1.00M
10-Q · filed 2020-11-12
2019-09-30$87.00K
10-Q · filed 2019-11-07
2019-06-30$140.00K
10-Q · filed 2019-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27